Losses of cyclin dependent kinase inhibitors, CDKN2A and CDKN2B, have been implicated as the tumor suppressor genes on chromosome 9p responsible for malignant meningioma phenotypes [10,25]. Here, CDKN2B is linked to neoplasm.